Berlin, Germany

Lasti Efrinanda Fuaadi

This inventor holds 1 USPTO granted patent. Top assignee: Borealis Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lasti Efrinanda Fuaadi. Retrieved from https://idiyas.com/inventor/lasti-efrinanda-fuaadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lasti Efrinanda Fuaadi: Patent Activity in Medical Innovation

Introduction

Lasti Efrinanda Fuaadi is an inventor associated with Berlin, Germany, and Borealis GmbH. His patent work concerns the potential medical use of CFTR modulators in conditions beyond cystic fibrosis.

Latest Patents

Fuaadi is associated with 1 patent, titled “Medical Use of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators.” The invention describes using a CFTR modulator to prevent or treat diseases involving endothelial or epithelial barrier dysfunction, excluding cystic fibrosis. It also covers pharmaceutical compositions containing a CFTR modulator, kits combining two CFTR modulators, and a treatment method involving administration of a CFTR modulator to a subject in need.

Career Highlights

Fuaadi’s listed patent activity connects his work at Borealis GmbH with research into therapeutic applications of CFTR modulators. The patent describes a potential approach to addressing barrier dysfunction through pharmaceutical treatment.

Collaborations

The listed coworkers associated with Fuaadi include Wolfgang Kübler and Birgitt Gutbier. Their names provide context for the professional network connected with this patent record.

Conclusion

Lasti Efrinanda Fuaadi’s patent focuses on exploring CFTR modulators as a possible treatment for diseases involving endothelial or epithelial barrier dysfunction, extending their proposed use beyond cystic fibrosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…